Nutranomics, Inc. (NNRX)

Market Cap	16.75K -97.9%
Revenue (ttm)	n/a -98.5%
Net Income	25.93K
EPS	0.00
Shares Out	16.75B
PE Ratio	0.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	1,025,060
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0001
Beta	-0.02
RSI	48.12
Earnings Date	n/a

About Nutranomics

Nutranomics, Inc. engages in the research, development, and sale of nutritional food products. It offers approximately 480 nutritional supplements, including formulating vitamin, mineral, herbal, and probiotic supplements. The company provides Nutritional Blood Analysis, a tool to examine the customer’s blood cells on a video monitor, live, in real time; and the patented Assimilation Enhancing System that improves the absorption of nutrients. In addition, it offers educational services, including various types of analyses, trainings, certificat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: NNRX

Financial Performance

In fiscal year 2020, Nutranomics's revenue was $871, a decrease of -98.54% compared to the previous year's $59,544. Losses were -$950,795, -57.52% less than in 2019.